Cargando…

Analyzing the emerging patterns of SARS‐CoV‐2 Omicron subvariants for the development of next‐gen vaccine: An observational study

BACKGROUND AND AIM: Understanding the prevalence and impact of SARS‐CoV‐2 variants has assumed paramount importance. This study statistically analyzed to effectively track the emergence and spread of the variants and highlights the importance of such investigations in developing potential next‐gen v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohapatra, Ranjan K., Mishra, Snehasish, Kandi, Venkataramana, Branda, Francesco, Ansari, Azaj, Rabaan, Ali A., Kudrat‐E‐Zahan, Md.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584996/ https://www.ncbi.nlm.nih.gov/pubmed/37867789 http://dx.doi.org/10.1002/hsr2.1596

Ejemplares similares

The neglected continuously emerging Marburg virus disease in Africa: A global public health threat
por: Srivastava, Devang, et al.
Publicado: (2023)

Another neglected tropical disease yellow fever re-emerges in African countries: Potential threat in the COVID-19 era which needs comprehensive investigations – Correspondence
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

Resurging dengue cases among the Rohingya refugees in Bangladesh amid COVID-19 pandemic: A SouthEast Asia healthcare concern
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

Possible threat of the Omicron subvariant BF.7 to FIH Hockey World Cup 2023 in particular and the South-East Asia Region in general
por: Mohapatra, Ranjan K., et al.
Publicado: (2023)

Deadly endemic zoonotic disease Ebola re-emerges in the democratic Republic of Congo amid the ongoing COVID-19: are we prepared from lessons learnt? – Correspondence
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

Emerging monkeypox cases amid the ongoing COVID-19 pandemic in the Indian subcontinent: A probable healthcare challenge for South East Asia
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

Monkeypox plays a similar role like SARS-CoV-2; intensive animal screening is crucial after the first human-to-dog transmission report – Correspondence
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

Monkeypox breakthrough infections and side-effects: Clarion call for nex-gen novel vaccine
por: Mohapatra, Ranjan K., et al.
Publicado: (2023)

Potential threat and possible global spread of the novel SARS-CoV-2 Omicron subvariants including XBB.1.16 during the Indian Premier League 2023: strict implementation of traveller guidelines suggested
por: Mohapatra, Ranjan K., et al.
Publicado: (2023)

Current Surge of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Variants in China Could Be Threatening as the Asian Games 2023 Flags Off in September: Foolproof Cautionary Measures Are Suggested
por: Mohapatra, Ranjan K, et al.
Publicado: (2023)

Monkeypox lineages amid the ongoing COVID-19 pandemic: A global public health concern – Correspondence
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

COVID-19 Era and the Constantly Reemerging Novel SARS-CoV-2 Variants Calls for Special Attention for the Geriatrics: A Real Challenge
por: Kutikuppala, L. V. Simhachalam, et al.
Publicado: (2022)

Recent surge in cholera outbreaks globally during the COVID-19 pandemic era: a potential threat to the African continent and salient counteracting strategies
por: Mohapatra, Ranjan K., et al.
Publicado: (2023)

Rift valley fever (RVF) viral zoonotic disease steadily circulates in the Mauritanian animals and humans: A narrative review
por: Mohapatra, Ranjan K., et al.
Publicado: (2023)

Editorial: Re-emergence of neglected tropical diseases amid the COVID-19 pandemic: epidemiology, transmission, mitigation strategies, and recent advances in chemotherapy and vaccines
por: Mohapatra, Ranjan K., et al.
Publicado: (2023)

The microbiota-related coinfections in COVID-19 patients: a real challenge
por: Mohapatra, Ranjan K., et al.
Publicado: (2021)

Emerging pneumonia-like illness “legionellosis” in Argentina in the COVID-19 era: Cause to panic?
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

Nanoadjuvants: Promising Bioinspired and Biomimetic Approaches in Vaccine Innovation
por: Desai, Dhruv N., et al.
Publicado: (2023)

COVID‐19 vaccines and their underbelly: Are we going the right way?
por: Satapathy, Bhabani Sankar, et al.
Publicado: (2023)

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
por: Wang, Xue-Jun, et al.
Publicado: (2022)

Genomic evidence for reinfection with different Omicron subvariants
por: Hirotsu, Yosuke, et al.
Publicado: (2023)

Durability of Bivalent Boosters against Omicron Subvariants
por: Lin, Dan-Yu, et al.
Publicado: (2023)

Detection of the Omicron BA.2.75 subvariant in Japan
por: Hirotsu, Yosuke, et al.
Publicado: (2023)

Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization
por: Morris, C. Paul, et al.
Publicado: (2022)

Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization
por: Morris, C Paul, et al.
Publicado: (2022)

Human-transmissible sarbecovirus ‘Khosta-2’ similar to SARS-CoV-2: potential global threat?
por: Mohapatra, Ranjan K., et al.
Publicado: (2023)

Immune Evasion of SARS-CoV-2 Omicron Subvariants
por: Ke, Hanzhong, et al.
Publicado: (2022)

Determinants and Mechanisms of the Low Fusogenicity and Endosomal Entry of Omicron Subvariants
por: Qu, Panke, et al.
Publicado: (2022)

Modelling the impact of the Omicron BA.5 subvariant in New Zealand
por: Lustig, Audrey, et al.
Publicado: (2023)

Protection against Reinfection with the Omicron BA.2.75 Subvariant
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Omicron subvariant BA.5 efficiently infects lung cells
por: Hoffmann, Markus, et al.
Publicado: (2023)

Structural Basis for the Enhanced Infectivity and Immune Evasion of Omicron Subvariants
por: Li, Yaning, et al.
Publicado: (2023)

The recent H3N2 viral outbreak in India, 2023: Is it worrying?
por: Boppana, Harsha, et al.
Publicado: (2023)

Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection
por: Jiang, Xiao-Lin, et al.
Publicado: (2023)

Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75
por: Takashita, Emi, et al.
Publicado: (2022)

Moving targets: COVID-19 vaccine efficacy against Omicron subvariants
por: da Silva, Maria Karolaynne, et al.
Publicado: (2022)

Reinfections with Different SARS-CoV-2 Omicron Subvariants, France
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Neutralization of Omicron Subvariant BA.2.75 after Bivalent Vaccination
por: Chalkias, Spyros, et al.
Publicado: (2022)

Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB
por: Uraki, Ryuta, et al.
Publicado: (2023)

Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection
por: Zhu, Ka-Li, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oami64r9gbaagjg1m8pp7i11gf